Lenka Cernohorská
Research Subjects
Lenka Cernohorská has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
M Votava
2 shared publicationsM. Votava
Masaryk University, and St. Anna’s Faculty Hospital
2 shared publicationsEva Chvílová
1 shared publication- Ivan Justan
RECETOX - Research Centre for Toxic Compounds in the Environment, Faculty of Science, Masaryk University, Kamenice 753/5, 625 00 Brno, Czech Republic
1 shared publication P Sláviková
1 shared publicationP. Slavicek
Department of Physical Electronics, Faculty of Science, Masaryk University, Brno, Czech Republic
1 shared publication
Latest Publications
- 25 January 2014
- Published by Springer Nature in Folia Microbiologica
- Vol. 59 (4) , 315-320
Plasma discharge and time-dependence of its effect to bacteria
Several types of plasma discharge have been proven to have a capacity for sterilization. Our goal is to introduce new nonthermal plasma pencil. We used it to sterilize different microbial populations with differing ages. We used a plasma discharge of the following characteristics: radio frequency barrier discharger at atmospheric pressure with a working frequency of 13.56 MHz, and the working gas used was argon. We performed 110 tests with the following microbial populations: Pseudomonas aeruginosa, Staphylococcus aureus, Proteus species, and Klebsiella pneumoniae. All populations were inoculated on the previous day and also on the day of our experiment. We made our evaluations the following day and also after 5 days, with all our microbial populations. Eradication of microbial populations is dependent on the plasma discharge exposure time in all cases. With regard to freshly inoculated microbes, we were able to sterilize agar with intensive exposure lasting for 10 s of colonies Pseudomonas, Proteus, and Klebsiella. The most resistant microbe seems to be S. aureus, which survives 5 s of coherent exposure in half of the cases. Using the lightest plasma discharge exposure, we achieved a maximum of 104–105 CFU/mL (colony-forming unit — CFU). Regarding older microbial populations inoculated the day before the experiment, we can only decrease population growth to 105 CFU/mL approximately, but never completely sterilize. The plasma discharge with our characteristics could be used for the sterilization of the aforementioned superficially growing microbes, but does not sufficiently affect deeper layers and thus seems to be a limitation for eradication of the already erupted colonies.
- 25 January 2014
- Published by Springer Nature in Folia Microbiologica
- Vol. 59 (4) , 315-320
Plasma discharge and time-dependence of its effect to bacteria
Several types of plasma discharge have been proven to have a capacity for sterilization. Our goal is to introduce new nonthermal plasma pencil. We used it to sterilize different microbial populations with differing ages. We used a plasma discharge of the following characteristics: radio frequency barrier discharger at atmospheric pressure with a working frequency of 13.56 MHz, and the working gas used was argon. We performed 110 tests with the following microbial populations: Pseudomonas aeruginosa, Staphylococcus aureus, Proteus species, and Klebsiella pneumoniae. All populations were inoculated on the previous day and also on the day of our experiment. We made our evaluations the following day and also after 5 days, with all our microbial populations. Eradication of microbial populations is dependent on the plasma discharge exposure time in all cases. With regard to freshly inoculated microbes, we were able to sterilize agar with intensive exposure lasting for 10 s of colonies Pseudomonas, Proteus, and Klebsiella. The most resistant microbe seems to be S. aureus, which survives 5 s of coherent exposure in half of the cases. Using the lightest plasma discharge exposure, we achieved a maximum of 104–105 CFU/mL (colony-forming unit — CFU). Regarding older microbial populations inoculated the day before the experiment, we can only decrease population growth to 105 CFU/mL approximately, but never completely sterilize. The plasma discharge with our characteristics could be used for the sterilization of the aforementioned superficially growing microbes, but does not sufficiently affect deeper layers and thus seems to be a limitation for eradication of the already erupted colonies.
- 1 June 2011
- Vol. 17 (3) , 81-5
[Proteus mirabilis isolated from urine, resistance to antibiotics and biofilm formation].
In the rather rare urinary pathogen Proteus mirabilis resistance to antibiotics and ability to form biofilm were studied. The strains Proteus mirabilis were isolated from urine samples from ambulatory and hospitalized patients diagnosed with urinary tract infection (UTI) between April 2008 and April 2010. Resistance to antibiotics was investigated using a disk diffusion antimicrobial susceptibility test. Biofilm formation was demonstrated by modified Christensen method. Two hundred and thirteen of P. mirabilis strains were tested. Eighty-two (38.5 %) strains were resistant to ampicillin, 49 (23.0 %) to cefalotin, 83 (39.0 %) to sulfamethoxazole/trimetoprim, 75 (35.2 %) to ciprofloxacin, 95 (44.6 %) to oxolinic acid, 54 (25.4 %) to gentamicin, and 72 (33.8 %) to chloramphenicol. There was significantly lower resistance to cefotaxime - 8 strains (3.8 %), ceftazidime - 8 (3.8 %), amoxicillin/clavulanic acid 17 (8.0 %) and aztreonam - 8 (3.8 %). No resistance to imipenem as well as to meropenem was found. Eight P. mirabilis strains were found to produce extended-spectrum beta-lactamase (ESBL). From the total of 213 strains tested, 28 (13.1 %) were able to form a biofilm. P. mirabilis was found to be more frequent in urine of men and older patients. Biofilm formation in urinary P. mirabilis strains was relatively low. The strains showed higher resistance to beta-lactams and quinolones; in the other cases, resistance was low.
- 1 June 2011
- Vol. 17 (3) , 81-5
[Proteus mirabilis isolated from urine, resistance to antibiotics and biofilm formation].
In the rather rare urinary pathogen Proteus mirabilis resistance to antibiotics and ability to form biofilm were studied. The strains Proteus mirabilis were isolated from urine samples from ambulatory and hospitalized patients diagnosed with urinary tract infection (UTI) between April 2008 and April 2010. Resistance to antibiotics was investigated using a disk diffusion antimicrobial susceptibility test. Biofilm formation was demonstrated by modified Christensen method. Two hundred and thirteen of P. mirabilis strains were tested. Eighty-two (38.5 %) strains were resistant to ampicillin, 49 (23.0 %) to cefalotin, 83 (39.0 %) to sulfamethoxazole/trimetoprim, 75 (35.2 %) to ciprofloxacin, 95 (44.6 %) to oxolinic acid, 54 (25.4 %) to gentamicin, and 72 (33.8 %) to chloramphenicol. There was significantly lower resistance to cefotaxime - 8 strains (3.8 %), ceftazidime - 8 (3.8 %), amoxicillin/clavulanic acid 17 (8.0 %) and aztreonam - 8 (3.8 %). No resistance to imipenem as well as to meropenem was found. Eight P. mirabilis strains were found to produce extended-spectrum beta-lactamase (ESBL). From the total of 213 strains tested, 28 (13.1 %) were able to form a biofilm. P. mirabilis was found to be more frequent in urine of men and older patients. Biofilm formation in urinary P. mirabilis strains was relatively low. The strains showed higher resistance to beta-lactams and quinolones; in the other cases, resistance was low.
- 1 December 2010
- Vol. 16 (6) , 196-8
[Antibiotic resistance and biofilm formation in Staphylococcus aureus strains isolated from urine].
The aim of this study was to evaluate antibiotic resistance and biofilm formation of Staphylococcus aureus strains, isolated from urine samples of patients with urinary tract infection. The samples were collected in the period of 2005-2009 and originated from patients of St. Anne's Teaching Hospital in Brno. A total of 128 S. aureus strains from 128 patients with the diagnosis of urinary tract infection were examined. In addition to testing the antibiotic resistance to doxycycline, vankomycin, nitrofurantoin, oxacillin, amoxicillin/clavulanate, cefoxitin and sulfamethoxazol/trimethoprim, biofilm was also detected in 112 strains by the modified Christensen method. No S. aureus strain resistant to vankomycin and nitrofrantoin was found, 12 strains were resistant to oxacillin (9.4 %), 6 to doxycyklin (4.7 %), 9 to amoxicillin/clavulanate (7.0 %) as well as to cefoxitine, and 2 to sulfamethoxazol/trimethoprim (1.6 %). Out of 20,375 positive urine samples examined in our laboratory between 2005 and 2009, S. aureus was detected as a causative agent of urinary tract infection in 0.6 %, being more frequent in males. Biofilm was produced by 14 (12.5 %) out of 112 S. aureus strains. The biofilm formation of urinary S. aureus strains was low. The strains showed higher resistance to beta-lactams, in other cases resistance was low. S. aureus was found to be more frequent in urine of older patients, males and after previous interventions using instrumental.
- 1 December 2010
- Vol. 16 (6) , 196-8
[Antibiotic resistance and biofilm formation in Staphylococcus aureus strains isolated from urine].
The aim of this study was to evaluate antibiotic resistance and biofilm formation of Staphylococcus aureus strains, isolated from urine samples of patients with urinary tract infection. The samples were collected in the period of 2005-2009 and originated from patients of St. Anne's Teaching Hospital in Brno. A total of 128 S. aureus strains from 128 patients with the diagnosis of urinary tract infection were examined. In addition to testing the antibiotic resistance to doxycycline, vankomycin, nitrofurantoin, oxacillin, amoxicillin/clavulanate, cefoxitin and sulfamethoxazol/trimethoprim, biofilm was also detected in 112 strains by the modified Christensen method. No S. aureus strain resistant to vankomycin and nitrofrantoin was found, 12 strains were resistant to oxacillin (9.4 %), 6 to doxycyklin (4.7 %), 9 to amoxicillin/clavulanate (7.0 %) as well as to cefoxitine, and 2 to sulfamethoxazol/trimethoprim (1.6 %). Out of 20,375 positive urine samples examined in our laboratory between 2005 and 2009, S. aureus was detected as a causative agent of urinary tract infection in 0.6 %, being more frequent in males. Biofilm was produced by 14 (12.5 %) out of 112 S. aureus strains. The biofilm formation of urinary S. aureus strains was low. The strains showed higher resistance to beta-lactams, in other cases resistance was low. S. aureus was found to be more frequent in urine of older patients, males and after previous interventions using instrumental.
- 1 April 2010
- Vol. 59 (2) , 88-91
[Antibiotic resistance and biofilm formation in Staphylococcus saprophyticus strains isolated from urine].
Eighty-seven Staphylococcus saprophyticus strains isolated from urine of 87 patients with cystitis were examined in 2005-2009. All strains were tested for resistance to vancomycin, nitrofurantoin, doxycycline, oxacillin, amoxicillin/clavulanate, cefoxitin and sulfamethoxazole/trimethoprim and for biofilm formation by a modified Christensen method. None of the tested strains of S. saprophyticus showed resistance to vancomycin, while 2 strains (2.3 %) were resistant to nitrofurantoin, 9 (10.3%) to doxycycline, 20 (23.0 %) to oxacillin, 6 (6.9%) to amoxicillin/clavulanate, 6 (6.9%) to cefoxitin and 1 (1.1%) to sulfamethoxazole/trimethoprim. S. saprophyticus was detected as the causative agent of cystitis in 0.4 % of 20,375 culture positive urine samples analyzed in our laboratory between 2005 and 2009. Most 67 (77.0%) S. saprophyticus strains were recovered from women, particularly from young women. Biofilm formation was detected in 16 (18.4 %) out of 87 S. saprophyticus strains.
- 1 April 2010
- Vol. 59 (2) , 88-91
[Antibiotic resistance and biofilm formation in Staphylococcus saprophyticus strains isolated from urine].
Eighty-seven Staphylococcus saprophyticus strains isolated from urine of 87 patients with cystitis were examined in 2005-2009. All strains were tested for resistance to vancomycin, nitrofurantoin, doxycycline, oxacillin, amoxicillin/clavulanate, cefoxitin and sulfamethoxazole/trimethoprim and for biofilm formation by a modified Christensen method. None of the tested strains of S. saprophyticus showed resistance to vancomycin, while 2 strains (2.3 %) were resistant to nitrofurantoin, 9 (10.3%) to doxycycline, 20 (23.0 %) to oxacillin, 6 (6.9%) to amoxicillin/clavulanate, 6 (6.9%) to cefoxitin and 1 (1.1%) to sulfamethoxazole/trimethoprim. S. saprophyticus was detected as the causative agent of cystitis in 0.4 % of 20,375 culture positive urine samples analyzed in our laboratory between 2005 and 2009. Most 67 (77.0%) S. saprophyticus strains were recovered from women, particularly from young women. Biofilm formation was detected in 16 (18.4 %) out of 87 S. saprophyticus strains.
- 1 November 2009
- Vol. 58 (4) , 154-7
[Antibiotic resistance and biofilm formation in Pseudomonas aeruginosa strains isolated from patients with urinary tract infections].
Altogether 118 Pseudomonas aeruginosa strains isolated from urine of patients with urinary tract infection were tested by the disk diffusion method for susceptibility to ciprofloxacin, ofloxacin, gentamicin, amikacin, colistin, meropenem, imipenem, piperacillin/tazobactam and ceftazidime. All strains were also screened for biofilm formation using a modified Christensen method. Eighty-eight, i.e., 74.6%, of the tested strains were resistant to ofloxacin, 86 (72.9%) to ciprofloxacin and 70 (59.3%) to gentamicin. Forty strains (33.9%) were resistant to imipenem, 42 strains (35.6%) to meropenem, 14 strains (11.9%) to amikacin, 2 strains (1.7%) to colistin, 35 strains (29.7%) to piperacillin/tazobactam and 41 strains (34.7%) to ceftazidime. Co-resistance to ofloxacin, ciprofloxacin and gentamicin was detected in 67 strains (56.8%) while 12 strains (10.2%) were resistant to most tested antibiotics, with the exception of amikacin and colistin. Biofilm formation was found in 41 strains (34.7%), more precisely in 23 of 46 inpatient strains and 18 of 72 outpatient strains. Eight (66.6%) of 12 polyresistant strains were biofilm producers.
- 1 November 2009
- Vol. 58 (4) , 154-7
[Antibiotic resistance and biofilm formation in Pseudomonas aeruginosa strains isolated from patients with urinary tract infections].
Altogether 118 Pseudomonas aeruginosa strains isolated from urine of patients with urinary tract infection were tested by the disk diffusion method for susceptibility to ciprofloxacin, ofloxacin, gentamicin, amikacin, colistin, meropenem, imipenem, piperacillin/tazobactam and ceftazidime. All strains were also screened for biofilm formation using a modified Christensen method. Eighty-eight, i.e., 74.6%, of the tested strains were resistant to ofloxacin, 86 (72.9%) to ciprofloxacin and 70 (59.3%) to gentamicin. Forty strains (33.9%) were resistant to imipenem, 42 strains (35.6%) to meropenem, 14 strains (11.9%) to amikacin, 2 strains (1.7%) to colistin, 35 strains (29.7%) to piperacillin/tazobactam and 41 strains (34.7%) to ceftazidime. Co-resistance to ofloxacin, ciprofloxacin and gentamicin was detected in 67 strains (56.8%) while 12 strains (10.2%) were resistant to most tested antibiotics, with the exception of amikacin and colistin. Biofilm formation was found in 41 strains (34.7%), more precisely in 23 of 46 inpatient strains and 18 of 72 outpatient strains. Eight (66.6%) of 12 polyresistant strains were biofilm producers.
- 1 November 2008
- Vol. 57 (4) , 141-6
[Detection of AmpC beta-lactamases in Gram-negative bacteria isolated from urine].
AmpC beta-lactamases, enzymes produced by a range of Gram-negative bacteria and able to hydrolyse penicillins, monobactams, cephalosporins and cephamycins, are not inhibited by beta-lactamase inhibitors. They are spread via plasmids and pose a huge epidemiological and diagnostic problem. The production of AmpC B-lactamases was tested in various Gram-negative bacteria. Of strains isolated from urine of patients diagnosed with urinary tract infection, we selected those that were resistant to third generation cephalosporins and did not produce extended-spectrum beta-lactamases (ESBL). The production of inducible AmpC was assayed by modified DDST (double disk synergy test) and that of constitutive AmpC was tested on agar containing oxacillin as an AmpC inhibitor. All constitutive AmpC producers were also tested for susceptibility to amikacin, piperacillin/tazobactam, cefoperazon/sulbactam, imipenem, meropenem and colistin by the disk diffusion method on MH-agar. Altoghether 119 strains (68 strains of Klebsiella pneumoniae, 20 strains of Escherichia coli and 12 strains of Enterobacter aerogenes) were tested. We detected 38 constitutive AmpC producers, including primarily K. pneumoniae (17 strains), E. coli (10 strains) and E. aerogenes (4 strains). Thirty-two strains were inducible AmpC producers (21 K pneumoniae strains, 6 Morganella morganii strains and 3 E. aerogenes strains). Two K. pneumoniae strains were ESBL/AmpC coproducers. The constitutive AmpC producers showed relatively good susceptibility to cefepim (84.2%) and carbapenems.
- 1 November 2008
- Vol. 57 (4) , 141-6
[Detection of AmpC beta-lactamases in Gram-negative bacteria isolated from urine].
AmpC beta-lactamases, enzymes produced by a range of Gram-negative bacteria and able to hydrolyse penicillins, monobactams, cephalosporins and cephamycins, are not inhibited by beta-lactamase inhibitors. They are spread via plasmids and pose a huge epidemiological and diagnostic problem. The production of AmpC B-lactamases was tested in various Gram-negative bacteria. Of strains isolated from urine of patients diagnosed with urinary tract infection, we selected those that were resistant to third generation cephalosporins and did not produce extended-spectrum beta-lactamases (ESBL). The production of inducible AmpC was assayed by modified DDST (double disk synergy test) and that of constitutive AmpC was tested on agar containing oxacillin as an AmpC inhibitor. All constitutive AmpC producers were also tested for susceptibility to amikacin, piperacillin/tazobactam, cefoperazon/sulbactam, imipenem, meropenem and colistin by the disk diffusion method on MH-agar. Altoghether 119 strains (68 strains of Klebsiella pneumoniae, 20 strains of Escherichia coli and 12 strains of Enterobacter aerogenes) were tested. We detected 38 constitutive AmpC producers, including primarily K. pneumoniae (17 strains), E. coli (10 strains) and E. aerogenes (4 strains). Thirty-two strains were inducible AmpC producers (21 K pneumoniae strains, 6 Morganella morganii strains and 3 E. aerogenes strains). Two K. pneumoniae strains were ESBL/AmpC coproducers. The constitutive AmpC producers showed relatively good susceptibility to cefepim (84.2%) and carbapenems.
- 1 January 2008
- Published by Springer Nature in Folia Microbiologica
- Vol. 53 (1) , 57-60
Antibiotic synergy against biofilm-forming Pseudomonas aeruginosa
Eight antibiotics (aztreonam, ceftazidim, cefoperazon, cefepim, netilmicin, amikacin, ofloxacin and ciprofloxacin) exhibited antimicrobial activity individually and/or in combinations against 20 wild-type biofilm-forming strains of Pseudomonas aeruginosa. The strains were less susceptible in biofilm; in 10 strains antibiotic synergy was observed for the combination of aztreonam and ciprofloxacin. Synergy was also demonstrated in the case of β-lactams and aminoglycosides, β-lactams and fluoroquinolones, aminoglycosides and fluoroquinolones, and for monobactams and β-lactams although the strains were resistant to the individual antibiotics. Synergism or partial synergism was found with one or more antibiotic combinations against 32.4% of isolates.
- 1 January 2008
- Published by Springer Nature in Folia Microbiologica
- Vol. 53 (1) , 57-60
Antibiotic synergy against biofilm-forming Pseudomonas aeruginosa
Eight antibiotics (aztreonam, ceftazidim, cefoperazon, cefepim, netilmicin, amikacin, ofloxacin and ciprofloxacin) exhibited antimicrobial activity individually and/or in combinations against 20 wild-type biofilm-forming strains of Pseudomonas aeruginosa. The strains were less susceptible in biofilm; in 10 strains antibiotic synergy was observed for the combination of aztreonam and ciprofloxacin. Synergy was also demonstrated in the case of β-lactams and aminoglycosides, β-lactams and fluoroquinolones, aminoglycosides and fluoroquinolones, and for monobactams and β-lactams although the strains were resistant to the individual antibiotics. Synergism or partial synergism was found with one or more antibiotic combinations against 32.4% of isolates.
- 1 January 2004
- Published by Springer Nature in Folia Microbiologica
- Vol. 49 (1) , 75-78
Determination of minimal regrowth concentration (MRC) in clinical isolates of various biofilm-forming bacteria
Based on the ability to attach to polymeric surfaces, the formation of biofilms was determined in 5 wild-type strains (Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter baumanii, Escherichia coli, Staphylococcus warneri). Using modified Christensen method, minimum regrowth concentration (MRC) of piperacillin, piperacillin-tazobactam, cefoperazon, ceftazidim, cefepim, meronem, ciprofloxacin, netilmicin and amikacin for Gram-negative and of ampicillin-sulbactam, chloramphenicol, tetracycline, clindamycin, vancomycin and teicoplanin for Gram-positive bacteria was estimated in trypticase-soy broth medium after a 1-d growth on polystyrene microtiter plates. Adherent bacterial populations exhibited reduced antimicrobial susceptibility, which was not shown in submerged cultures. Our results indicate that MRC can predict therapeutic outcome of antibiotic treatment better than the minimum inhibitory concentration tests commonly used.
- 1 January 2004
- Published by Springer Nature in Folia Microbiologica
- Vol. 49 (1) , 75-78
Determination of minimal regrowth concentration (MRC) in clinical isolates of various biofilm-forming bacteria
Based on the ability to attach to polymeric surfaces, the formation of biofilms was determined in 5 wild-type strains (Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter baumanii, Escherichia coli, Staphylococcus warneri). Using modified Christensen method, minimum regrowth concentration (MRC) of piperacillin, piperacillin-tazobactam, cefoperazon, ceftazidim, cefepim, meronem, ciprofloxacin, netilmicin and amikacin for Gram-negative and of ampicillin-sulbactam, chloramphenicol, tetracycline, clindamycin, vancomycin and teicoplanin for Gram-positive bacteria was estimated in trypticase-soy broth medium after a 1-d growth on polystyrene microtiter plates. Adherent bacterial populations exhibited reduced antimicrobial susceptibility, which was not shown in submerged cultures. Our results indicate that MRC can predict therapeutic outcome of antibiotic treatment better than the minimum inhibitory concentration tests commonly used.
- 1 November 2002
- Vol. 51 (4) , 161-4
[Biofilms and their significance in medical microbiology].
Microorganisms are able to adhere to various surfaces and to form there a three-dimensional structure known as biofilm. In biofilms, microbial cells show characteristics and behaviours different from those of plankton cells. Intercellular signalizations of the quorum-sensing type regulate interaction between members of the biofilm. Bacteria embedded in the biofilm can escape and form well known planktonic forms, that are obviously only a part of the bacterial life cycle. Bacteria adhere also to medically important surfaces such as catheters, either urinary or intravenous ones, artificial heart valves, orthopedic implants and so on and contribute to device-related infections like cystitis, catheter-related sepsis, endocarditis etc. Once a biofilm has been established on a surface, the bacteria harboured inside are less exposed to the host's immune response and less susceptible to antibiotics. As an important cause of nosocomial infections the biofilm must remain in the centre of the microbiologist's attention.
- 1 November 2002
- Vol. 51 (4) , 161-4
[Biofilms and their significance in medical microbiology].
Microorganisms are able to adhere to various surfaces and to form there a three-dimensional structure known as biofilm. In biofilms, microbial cells show characteristics and behaviours different from those of plankton cells. Intercellular signalizations of the quorum-sensing type regulate interaction between members of the biofilm. Bacteria embedded in the biofilm can escape and form well known planktonic forms, that are obviously only a part of the bacterial life cycle. Bacteria adhere also to medically important surfaces such as catheters, either urinary or intravenous ones, artificial heart valves, orthopedic implants and so on and contribute to device-related infections like cystitis, catheter-related sepsis, endocarditis etc. Once a biofilm has been established on a surface, the bacteria harboured inside are less exposed to the host's immune response and less susceptible to antibiotics. As an important cause of nosocomial infections the biofilm must remain in the centre of the microbiologist's attention.